長期投資家のためのIR情報
バリュートレンド

【6869】シスメックス
検体検査機器・試薬。
類似企業:

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/08/07 Q1予 545,000 ↑ +1.9% +1.9% 60,000 ↑ +3.4% +3.4% 56,000 ↑ +3.7% +3.7% 37,000 ↑ +2.8% +2.8%
2027.03 2026/05/14 当初予 535,000 - - - 58,000 - - - 54,000 - - - 36,000 - - -
2026.03 2026/05/14 実 500,006 ↑ +0.0% -6.5% 51,831 ↓ -16.4% -43.4% 49,051 ↓ -16.9% -42.6% 35,457 ↓ -13.5% -37.8%
2026.03 2026/02/12 Q3予 500,000 ↓ -2.0% -6.5% 62,000 ↓ -18.4% -32.2% 59,000 ↓ -16.9% -31.0% 41,000 ↓ -8.9% -28.1%
2026.03 2025/11/05 Q2予 510,000 ↓ -4.7% -4.7% 76,000 ↓ -16.9% -16.9% 71,000 ↓ -17.0% -17.0% 45,000 ↓ -21.1% -21.1%
2026.03 2025/08/06 Q1予 535,000 → 0.0% 0.0% 91,500 → 0.0% 0.0% 85,500 → 0.0% 0.0% 57,000 → 0.0% 0.0%
2026.03 2025/05/14 当初予 535,000 - - - 91,500 - - - 85,500 - - - 57,000 - - -
2025.03 2025/05/14 実 508,643 ↓ -0.3% -0.3% 87,583 ↓ -2.7% +0.7% 79,221 ↓ -4.0% -4.0% 53,669 ↓ -2.4% -2.4%
2025.03 2025/02/12 Q3予 510,000 → 0.0% 0.0% 90,000 → 0.0% +3.4% 82,500 → 0.0% 0.0% 55,000 → 0.0% 0.0%
2025.03 2024/11/06 Q2予 510,000 → 0.0% 0.0% 90,000 ↑ +3.4% +3.4% 82,500 → 0.0% 0.0% 55,000 → 0.0% 0.0%
2025.03 2024/08/06 Q1予 510,000 → 0.0% 0.0% 87,000 → 0.0% 0.0% 82,500 → 0.0% 0.0% 55,000 → 0.0% 0.0%
2025.03 2024/05/09 当初予 510,000 - - - 87,000 - - - 82,500 - - - 55,000 - - -
2024.03 2024/05/09 実 461,510 ↑ +0.3% +0.3% 78,382 ↓ -5.6% -5.6% 74,600 ↓ -4.4% -4.4% 49,639 ↓ -4.5% -4.5%
2024.03 2024/02/09 Q3予 460,000 → 0.0% 0.0% 83,000 → 0.0% 0.0% 78,000 → 0.0% 0.0% 52,000 → 0.0% 0.0%
2024.03 2023/11/08 Q2予 460,000 → 0.0% 0.0% 83,000 → 0.0% 0.0% 78,000 → 0.0% 0.0% 52,000 → 0.0% 0.0%
2024.03 2023/08/08 Q1予 460,000 → 0.0% 0.0% 83,000 → 0.0% 0.0% 78,000 → 0.0% 0.0% 52,000 → 0.0% 0.0%
2024.03 2023/05/11 当初予 460,000 - - - 83,000 - - - 78,000 - - - 52,000 - - -
2023.03 2023/05/11 実 410,502 ↓ -2.3% +0.1% 73,679 ↓ -4.3% -3.1% 68,713 ↓ -7.8% -5.2% 45,784 ↓ -10.2% -8.4%
2023.03 2023/02/09 Q3予 420,000 → 0.0% +2.4% 77,000 → 0.0% +1.3% 74,500 → 0.0% +2.8% 51,000 → 0.0% +2.0%
2023.03 2022/11/09 Q2予 420,000 ↑ +2.4% +2.4% 77,000 ↑ +1.3% +1.3% 74,500 ↑ +2.8% +2.8% 51,000 ↑ +2.0% +2.0%
2023.03 2022/08/04 Q1予 410,000 → 0.0% 0.0% 76,000 → 0.0% 0.0% 72,500 → 0.0% 0.0% 50,000 → 0.0% 0.0%
2023.03 2022/05/12 当初予 410,000 - - - 76,000 - - - 72,500 - - - 50,000 - - -
2022.03 2022/05/12 実 363,780 ↑ +1.0% +3.9% 67,416 ↑ +2.1% +12.4% 64,346 ↑ +2.1% +12.9% 44,093 ↑ +0.2% +10.2%
2022.03 2022/02/10 Q3予 360,000 → 0.0% +2.9% 66,000 → 0.0% +10.0% 63,000 → 0.0% +10.5% 44,000 → 0.0% +10.0%
2022.03 2021/11/10 Q2予 360,000 ↑ +2.9% +2.9% 66,000 ↑ +10.0% +10.0% 63,000 ↑ +10.5% +10.5% 44,000 ↑ +10.0% +10.0%
2022.03 2021/08/06 Q1予 350,000 → 0.0% 0.0% 60,000 → 0.0% 0.0% 57,000 → 0.0% 0.0% 40,000 → 0.0% 0.0%
2022.03 2021/05/12 当初予 350,000 - - - 60,000 - - - 57,000 - - - 40,000 - - -
2021.03 2021/05/12 実 305,073 ↓ -1.6% -1.6% 51,792 ↑ +6.8% +6.8% 48,033 ↑ +8.9% +8.9% 33,142 ↑ +7.6% +7.6%
2021.03 2021/02/03 Q3予 310,000 → 0.0% 0.0% 48,500 → 0.0% 0.0% 44,100 → 0.0% 0.0% 30,800 → 0.0% 0.0%
2021.03 2020/11/05 当初予 310,000 - - - 48,500 - - - 44,100 - - - 30,800 - - -
2020.03 2020/05/12 実 301,980 ↓ -2.6% -5.6% 55,284 ↓ -7.9% -13.6% 49,433 ↓ -10.1% -17.6% 34,883 ↓ -9.4% -16.9%
2020.03 2020/02/05 Q3予 310,000 → 0.0% -3.1% 60,000 → 0.0% -6.3% 55,000 → 0.0% -8.3% 38,500 → 0.0% -8.3%
2020.03 2019/11/06 Q2予 310,000 ↓ -3.1% -3.1% 60,000 ↓ -6.3% -6.3% 55,000 ↓ -8.3% -8.3% 38,500 ↓ -8.3% -8.3%
2020.03 2019/08/02 Q1予 320,000 → 0.0% 0.0% 64,000 → 0.0% 0.0% 60,000 → 0.0% 0.0% 42,000 → 0.0% 0.0%
2020.03 2019/05/08 当初予 320,000 - - - 64,000 - - - 60,000 - - - 42,000 - - -
2019.03 2019/05/08 実 293,506 ↓ -2.2% -5.3% 61,282 ↑ +3.9% -1.2% 57,955 ↑ +3.5% -3.4% 41,224 ↑ +4.4% -3.0%
2019.03 2019/02/06 Q3予 300,000 → 0.0% -3.2% 59,000 → 0.0% -4.8% 56,000 → 0.0% -6.7% 39,500 → 0.0% -7.1%
2019.03 2018/11/07 Q2予 300,000 ↓ -3.2% -3.2% 59,000 ↓ -4.8% -4.8% 56,000 ↓ -6.7% -6.7% 39,500 ↓ -7.1% -7.1%
2019.03 2018/08/03 Q1予 310,000 → 0.0% 0.0% 62,000 → 0.0% 0.0% 60,000 → 0.0% 0.0% 42,500 → 0.0% 0.0%
2019.03 2018/05/09 当初予 310,000 - - - 62,000 - - - 60,000 - - - 42,500 - - -
2018.03 2018/05/09 実 281,935 ↑ +0.7% +2.5% 59,078 ↑ +1.9% +3.6% 58,117 ↑ +0.2% +3.8% 39,222 ↓ -5.5% -4.3%
2018.03 2018/02/06 Q3予 280,000 → 0.0% +1.8% 58,000 → 0.0% +1.8% 58,000 → 0.0% +3.6% 41,500 → 0.0% +1.2%
2018.03 2017/11/08 Q2予 280,000 ↑ +1.8% +1.8% 58,000 ↑ +1.8% +1.8% 58,000 ↑ +3.6% +3.6% 41,500 ↑ +1.2% +1.2%
2018.03 2017/08/04 Q1予 275,000 → 0.0% 0.0% 57,000 → 0.0% 0.0% 56,000 → 0.0% 0.0% 41,000 → 0.0% 0.0%
2018.03 2017/05/10 当初予 275,000 - - - 57,000 - - - 56,000 - - - 41,000 - - -
2017.03 2017/05/10 実 249,899 ↓ -2.0% -9.1% 51,701 ↓ -6.0% -16.6% 48,946 ↓ -7.3% -20.4% 40,636 ↓ -6.6% +0.3%
2017.03 2017/02/03 Q3予 255,000 ↓ -7.3% -7.3% 55,000 ↓ -11.3% -11.3% 52,800 ↓ -14.1% -14.1% 43,500 ↑ +7.4% +7.4%
2017.03 2016/08/05 当初予 275,000 - - - 62,000 - - - 61,500 - - - 40,500 - - -
2016.03 2016/05/11 実 - - - - - - - - - - - - - - - -
2016.03 2016/02/03 Q3予 252,000 → 0.0% +2.9% 52,000 → 0.0% +4.0% 51,400 → 0.0% +2.8% 33,000 → 0.0% +3.8%
2016.03 2015/11/05 Q2予 252,000 ↑ +2.9% +2.9% 52,000 ↑ +4.0% +4.0% 51,400 ↑ +2.8% +2.8% 33,000 ↑ +3.8% +3.8%
2016.03 2015/08/05 Q1予 245,000 → 0.0% 0.0% 50,000 - - - 50,000 → 0.0% 0.0% 31,800 → 0.0% 0.0%
2016.03 2015/05/12 当初予 245,000 - - - - - - - 50,000 - - - 31,800 - - -
2015.03 2015/05/12 実 - - - - - - - - - - - - - - - -
2015.03 2015/02/04 Q3予 210,000 → 0.0% 0.0% 41,000 → 0.0% +13.9% 40,700 → 0.0% +13.1% 24,900 → 0.0% +13.2%
2015.03 2014/11/05 Q2予 210,000 → 0.0% 0.0% 41,000 ↑ +13.9% +13.9% 40,700 ↑ +13.1% +13.1% 24,900 ↑ +13.2% +13.2%
2015.03 2014/08/05 Q1予 210,000 → 0.0% 0.0% 36,000 → 0.0% 0.0% 36,000 → 0.0% 0.0% 22,000 → 0.0% 0.0%
2015.03 2014/05/08 当初予 210,000 - - - 36,000 - - - 36,000 - - - 22,000 - - -
2014.03 2014/05/08 実 184,538 - - - 32,870 - - - 33,782 - - - 20,573 - - -
シェア ツイート
ページトップへ戻る